D C Teoh, S Rodger, J Say, A Hartley. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useCarcinoma, Squamous Cell/drug therapyCarcinoma, Squamous Cell/radiotherapyCetuximabCombined Modality TherapyDose Fractionation, RadiationHead and Neck Neoplasms/drug therapyHead and Neck Neoplasms/radiotherapyHumansMulticenter Studies as TopicRadiodermatitis/chemically inducedRadiodermatitis/etiology
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsCetuximab
Year: 2008 PMID： 18757187 DOI： 10.1016/j.clon.2008.07.003
Source DB: PubMed Journal: Clin Oncol (R Coll Radiol) ISSN： 0936-6555 Impact factor: 4.126